These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 7051392

  • 1. [Criteria of the effectiveness of antirheumatic agents in controlled clinical trials].
    Pavelka K.
    Ter Arkh; 1982; 54(6):106-9. PubMed ID: 7051392
    [No Abstract] [Full Text] [Related]

  • 2. [Anti-inflammatory or antirheumatic agents? Pharmacological activity and therapeutic effectiveness of non-steroid anti-inflammatory drugs: comparative study. III].
    Mariani L, Baratelli M.
    Clin Ter; 1980 Feb 29; 92(4):331-58. PubMed ID: 7004749
    [No Abstract] [Full Text] [Related]

  • 3. Recent clinical trials in the rheumatic diseases.
    Matteson EL.
    Curr Opin Rheumatol; 1997 Mar 29; 9(2):95-101. PubMed ID: 9135911
    [Abstract] [Full Text] [Related]

  • 4. Interpreting clinical trials of antirheumatic drug therapy.
    Bellamy N, Buchanan WW.
    Bull Rheum Dis; 1986 Mar 29; 36(2):1-10. PubMed ID: 3493823
    [No Abstract] [Full Text] [Related]

  • 5. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL, Gause A.
    Z Rheumatol; 2003 Jun 29; 62(3):217. PubMed ID: 12931691
    [No Abstract] [Full Text] [Related]

  • 6. [A field study: piroxicam in arthrosis and soft tissue rheumatism. Results of a multicenter study].
    Knüsel O, Hinz G.
    Schweiz Rundsch Med Prax; 1983 Sep 13; 72(37):1189-94. PubMed ID: 6356121
    [No Abstract] [Full Text] [Related]

  • 7. [Bumadizone-calcium in rheumatic diseases. Clinical study].
    Bröll H, Tausch G, Sochor H, Eberl R.
    MMW Munch Med Wochenschr; 1974 Feb 15; 116(15):339-40. PubMed ID: 4209902
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical experimentation of calcium bucloxate (804 CB) in rheumatology].
    Louyot P, Tamisier JN, Pourel J.
    Arzneimittelforschung; 1974 Sep 15; 24(9A SUPPL):1428-31. PubMed ID: 4614820
    [No Abstract] [Full Text] [Related]

  • 10. [Problems in experimental and clinical trials of antirheumatic agents].
    Trnavský K.
    Cesk Farm; 1983 May 15; 32(3-4):145-8. PubMed ID: 6347403
    [No Abstract] [Full Text] [Related]

  • 11. [Trial of 16 091 R.P. (metiazinic acid) in general medicine].
    Dalmais J, Fuvel M.
    J Med Lyon; 1971 Oct 05; 52(214):1243-6. PubMed ID: 4944457
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec 05; 5(3):320-6. PubMed ID: 5317064
    [No Abstract] [Full Text] [Related]

  • 15. [Site and mode of action of antirheumatic agents].
    Mathies H.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Oct 05; 5(2):179-86. PubMed ID: 5316307
    [No Abstract] [Full Text] [Related]

  • 16. Anti-rheumatic drugs III.
    Clin Rheum Dis; 1984 Aug 05; 10(2):217-432. PubMed ID: 6334585
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials].
    Pavelka K, Vojtísek D, Kañkova D, Perlík F, Pelísková Z.
    Fysiatr Revmatol Vestn; 1982 Jan 05; 60(1):1-10. PubMed ID: 7040188
    [No Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory drugs in the treatment of rheumatic diseases.
    Hart FD.
    Practitioner; 1970 Nov 05; 205(229):597-603. PubMed ID: 5312818
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.